IP Verse

Controlled Release Pharmaceutical Composition

Patent No. EP2345410 (titled "Controlled Release Pharmaceutical Composition") was filed by Astellas Pharma on Sep 28, 2009. The application was issued on Dec 30, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERSep 30, 2021BRAND MURRAY FULLER
TEVA PHARMACEUTICALSSep 30, 2021D YOUNG
BULLE DRSep 29, 2021KUTZENBERGER WOLFF & PARTNER
HAMM & WITTKOPPSep 29, 2021HAMM & WITTKOPP
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETISep 29, 2021SONNENHAUSER
SANDOZSep 23, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2345410

ASTELLAS PHARMA
Application Number
EP09817723A
Filing Date
Sep 28, 2009
Status
Granted And Under Opposition
Nov 27, 2020
Publication Date
Dec 30, 2020
External Links
Slate, Register , Google Patents